TickerFacts.

Akso Health Group (AHG): R&D Expense

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest R&D Expense is for the year ended 2022-03-31, while the company's latest annual report covers the year ended 2026-03-31. Its later filings do not report this line under the concept TickerFacts maps.

$421.2K
Year ended 2022-03-31
-23.1%
5-year compound annual growth
$2.82M2016-03-31: $896.0K2017-03-31: $1.57M2018-03-31: $2.82M2019-03-31: $02020-03-31: $117.9K2021-03-31: $441.4K2022-03-31: $421.2K$421.2K
2016-03-31 R&D Expense (USD) 2022-03-31
Period endedR&D ExpenseChange YoYSource filing
2022-03-31$421.2K-4.6%2022-12-29, From 2021-04-01
2021-03-31$441.4K+274.3%2022-12-29, From 2020-04-01
2020-03-31$117.9Kn/a2022-12-29, From 2019-04-01
2019-03-31$0-100.0%2021-07-28, From 2018-04-01
2018-03-31$2.82M+79.7%2020-08-14, From 2017-04-01
2017-03-31$1.57M+75.0%2019-07-31, From 2016-04-01
2016-03-31$896.0Kn/a2018-07-30, From 2015-04-01